An interesting case of life-threatening COVID-19 pneumonia

COVID-19 pneumonia requires intensive care unit admission in approximately 5% of patients. The treatment options are all experimental. We report a case of life-threatening COVID-19 pneumonia with cytokine release syndrome who had successful outcome with tocilizumab.

Bibliographic Details
Main Authors:	Sudha Kansal, Aakanksha Chawla Jain, M S Kanwar, Avdhesh Bansal, Nikhil Modi, Athar Parvez Ansari, Roseleen Kaur Bali, Viny Kantroo, Rajesh Chawla
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Apollo Medicine
Subjects:	covid-19 cytokine release syndrome tocilizumab
Online Access:	http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2020;volume=17;issue=5;spage=62;epage=64;aulast=Kansal

Internet

http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2020;volume=17;issue=5;spage=62;epage=64;aulast=Kansal

An interesting case of life-threatening COVID-19 pneumonia

Internet

Similar Items